LOW CONCENTRATION OF CITRATE IN AN ADALIMUMAB FORMULATION DOES NOT IMPACT THE INTENSITY OF INJECTION SITE PAIN: EVALUATION FOLLOWING A SINGLE DOSE OF GP2017, A LOW CONCENTRATION ADALIMUMAB BIOSIMILAR VERSUS HIGH CONCENTRATION ADALIMUMAB CITRATE-FREE FORMU

Juan Carlos Rondon  1     Constanze Fey  2     Oliver von Richter  2     Jamie Fan  3     Fabricio Furlan  3     Lena Lemke  3    
1 Clinical Pharmacology of Miami, LLC, Miami, United States
2 Hexal AG (A Sandoz company), Holzkirchen, Germany
3 Sandoz Inc., Princeton Corporate, Princeton, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing